A Médecins Sans Frontières hospital in South Sudan's Jonglei State was struck by an aerial bombardment attributed to government forces overnight, destroying critical medical supplies and injuring staff, just hours after another MSF facility was looted.
UK-based Futura Medical secures a key US patent allowance, safeguarding its erectile dysfunction gel Eroxon and an investigational women's sexual health treatment until 2040, while triggering a $2.5 million milestone payment from partner Haleon.
An analysis using the Discounted Cash Flow model suggests MeVis Medical Solutions AG (ETR:M3V) is trading close to its estimated intrinsic value. While the model provides a framework, experts caution that valuation is an art as much as a science, dependent on key assumptions about growth and risk.
UK-based Futura Medical has upgraded its full-year revenue forecast to £1.7 million for 2025, citing strong performance of its over-the-counter erectile dysfunction gel Eroxon. The announcement comes as the company prepares for a strategic review and anticipates key financial catalysts, including a milestone payment from partner Haleon.
Shares in Futura Medical PLC jumped as much as 10% after the company upgraded its 2025 revenue forecast to £1.7 million and reported a robust year-end cash balance, extending its financial runway into late 2026.
Aurora Cannabis reports a strategic overhaul in its fiscal Q3 2026 results, pivoting resources away from the competitive Canadian recreational market to focus on higher-margin international medical cannabis. The move, alongside plans to divest its Bevo stake, signals a decisive shift towards profitability as the company posts steady revenue growth led by its German and Polish operations.
Aurora Cannabis reports a 7% rise in Q3 revenue, fueled by record international medical cannabis sales. The company announces a strategic pivot to exit lower-margin Canadian consumer operations, betting big on high-growth regulated markets in Europe and Australia.
Benchmark Electronics (BHE) reported Q4 revenue and profit that topped analyst forecasts, driven by strength in medical devices and advanced computing. While margins face pressure, management pointed to robust new bookings and a planned capacity expansion to fuel future growth.
Despite Select Medical's shares outperforming the S&P 500 by 15.8% over the past six months, a closer look reveals concerning trends in patient admissions, profitability, and capital returns that warrant investor caution.
Analysts are recalibrating expectations for Treace Medical Concepts, lowering price targets despite a steady fair value estimate. The adjustments reflect concerns over uneven demand patterns, the distorting effect of one-time distributor orders, and questions about the company's operational execution in a challenging market.
With only a trickle of patients allowed out, UN Secretary-General Antonio Guterres calls for immediate humanitarian access to Gaza, as medical officials warn blocked evacuations are tantamount to a 'death sentence' for thousands.
In its Q4 2025 letter, Baron Discovery Fund pointed to medical technology firm Establishment Labs Holdings (ESTA) as a key contributor, despite the fund's slight underperformance against its benchmark. The fund remains optimistic about a high-growth, low-inflation environment in 2026.
The World Health Organization confirms the first medical evacuations from Gaza via the reopened Rafah crossing, a critical lifeline for over 18,500 patients awaiting urgent care after two years of conflict.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
The reopening of Gaza's Rafah crossing for medical evacuations brought a glimmer of hope, but stringent Israeli restrictions limited departures to just five patients on the first day, leaving thousands in critical need still waiting.
The Hennepin County Medical Examiner has officially classified the January shooting death of ICU nurse Alex Pretti as a homicide, a finding that intensifies legal and public pressure on the federal agents involved amid ongoing protests and disputed official narratives.
The Rafah border crossing between Gaza and Egypt has partially reopened under the terms of the US-brokered ceasefire, permitting a limited number of medical evacuations for the first time in nearly two years, as tens of thousands await passage.
Tilray Brands deepens its commitment to Europe's regulated medical cannabis sector with the launch of Tilray Medical Italia, a strategic venture with local partner Molteni Farmaceutici. The move comes as the company seeks to stabilize its growth narrative amid significant stock market volatility.
Medical Properties Trust (NYSE: MPW), a major healthcare real estate investment trust, is relocating its corporate headquarters to Birmingham, Alabama. The move is seen as a strategic effort to streamline operations and deepen ties with its primary U.S. hospital network, lenders, and investors, amid an evolving landscape for hospital ownership and healthcare infrastructure.
Ahead of its February 26 earnings report, Medical Properties Trust (NYSE: MPW) is witnessing a notable spike in options activity, with call volume soaring to roughly five times its usual level. This surge in speculative interest comes as the healthcare REIT's shares hover around $5.05, showing recent momentum but still grappling with a challenging multi-year performance. Analysts are divided on whether the stock's current price reflects lingering past troubles or is beginning to price in a potential recovery narrative.
